# Interest in the Use of Nasal High-Flow Oxygen Therapy (OptiFlow™) in Secondary Transport of COVID-19 Positive Patients

> **NCT05289141** · — · COMPLETED · sponsor: **Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer** · enrollment: 229 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DEVICE:** Use of high flow nasal oxygen therapy
- **DEVICE:** Use of other non-invasive ventilation or high concentration oxygen masks

## Key facts

- **NCT ID:** NCT05289141
- **Lead sponsor:** Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-24
- **Primary completion:** 2022-04-25
- **Final completion:** 2022-04-25
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2022-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05289141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05289141, "Interest in the Use of Nasal High-Flow Oxygen Therapy (OptiFlow™) in Secondary Transport of COVID-19 Positive Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05289141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*